Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.8B |
| FY2017, ended Dec 31, 2017 | $43.0B |
| FY2018, ended Dec 31, 2018 | $42.2B |
| FY2019, ended Dec 31, 2019 | $66.6B |
| FY2020, ended Dec 31, 2020 | $79.1B |
| FY2021, ended Dec 31, 2021 | $114B |
| FY2022, ended Dec 31, 2022 | $108B |
| FY2023, ended Dec 31, 2023 | $138B |
| FY2024, ended Dec 31, 2024 | $153B |
| FY2025, ended Dec 31, 2025 | $156B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $114B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.66B |
| FY2017, ended Dec 31, 2017 | $6.06B |
| FY2018, ended Dec 31, 2018 | $6.26B |
| FY2019, ended Dec 31, 2019 | $6.70B |
| FY2020, ended Dec 31, 2020 | $7.44B |
| FY2021, ended Dec 31, 2021 | $8.30B |
| FY2022, ended Dec 31, 2022 | $11.2B |
| FY2023, ended Dec 31, 2023 | $12.5B |
| FY2024, ended Dec 31, 2024 | $14.2B |
| FY2025, ended Dec 31, 2025 | $15.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $16.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.11B | $1.45B |
| FY2017, ended Dec 31, 2017 | $1.50B | $1.89B |
| FY2018, ended Dec 31, 2018 | $1.96B | $1.95B |
| FY2019, ended Dec 31, 2019 | $2.12B | $2.66B |
| FY2020, ended Dec 31, 2020 | $2.34B | $3.49B |
| FY2021, ended Dec 31, 2021 | $3.02B | $3.56B |
| FY2022, ended Dec 31, 2022 | $3.25B | $2.51B |
| FY2023, ended Dec 31, 2023 | $2.63B | $3.57B |
| FY2024, ended Dec 31, 2024 | $3.85B | $5.57B |
| FY2025, ended Dec 31, 2025 | $4.47B | $5.46B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.99B | $5.25B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.39B |
| FY2017, ended Dec 31, 2017 | $2.78B |
| FY2018, ended Dec 31, 2018 | $1.92B |
| FY2019, ended Dec 31, 2019 | $2.87B |
| FY2020, ended Dec 31, 2020 | $4.11B |
| FY2021, ended Dec 31, 2021 | $6.50B |
| FY2022, ended Dec 31, 2022 | $1.29B |
| FY2023, ended Dec 31, 2023 | $1.29B |
| FY2024, ended Dec 31, 2024 | $1.67B |
| FY2025, ended Dec 31, 2025 | $1.71B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.44B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.56B |
| FY2017, ended Dec 31, 2017 | $3.57B |
| FY2018, ended Dec 31, 2018 | $3.66B |
| FY2019, ended Dec 31, 2019 | $3.95B |
| FY2020, ended Dec 31, 2020 | $4.11B |
| FY2021, ended Dec 31, 2021 | $4.11B |
| FY2022, ended Dec 31, 2022 | $11.0B |
| FY2023, ended Dec 31, 2023 | $11.5B |
| FY2024, ended Dec 31, 2024 | $11.4B |
| FY2025, ended Dec 31, 2025 | $13.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 12.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 258M |
| FY2017, ended Dec 31, 2017 | 254M |
| FY2018, ended Dec 31, 2018 | 249M |
| FY2019, ended Dec 31, 2019 | 244M |
| FY2020, ended Dec 31, 2020 | 241M |
| FY2021, ended Dec 31, 2021 | 241M |
| FY2022, ended Dec 31, 2022 | 322M |
| FY2023, ended Dec 31, 2023 | 314M |
| FY2024, ended Dec 31, 2024 | 307M |
| FY2025, ended Dec 31, 2025 | 299M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 290M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.12B | $76.0M | — |
| FY2017, ended Dec 31, 2017 | $1.00B | $99.0M | — |
| FY2018, ended Dec 31, 2018 | $1.66B | $94.0M | $352M |
| FY2019, ended Dec 31, 2019 | $1.24B | $78.0M | — |
| FY2020, ended Dec 31, 2020 | $1.16B | $90.0M | — |
| FY2021, ended Dec 31, 2021 | $0 | $122M | — |
| FY2022, ended Dec 31, 2022 | $12.0B | $214M | $43.5B |
| FY2023, ended Dec 31, 2023 | $3.30B | $171M | — |
| FY2024, ended Dec 31, 2024 | $3.30B | $247M | — |
| FY2025, ended Dec 31, 2025 | $5.00B | $236M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.60B | $208M | — |
Valuation
At current price- Market Cap
- $130B
- P/E
- 26.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 8.0×
- Price / Book
- 6.6×
- EV / EBITDA
- 15.9×
Growth
Trailing 12 months- Revenue (TTM)
- $16.3B
- Revenue Growth YoY
- 18.8%
- Revenue CAGR 3Y
- 11.1%
- Revenue CAGR 5Y
- 15.6%
- EPS Growth YoY
- 22.3%
- Net Income Growth YoY
- 18.2%
Profitability
Trailing 12 months- Gross Margin
- 71.0%
- Operating Margin
- 46.8%
- Net Margin
- 30.6%
- FCF Margin
- 32.2%
- Return on Equity
- 18.9%
Earnings
Trailing 12 months- Net Income
- $4.99B
- EPS (diluted)
- $16.82
- EBITDA
- $8.85B
- Operating Income
- $7.63B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $2.44B
- Total Debt
- $13.1B
- Net Debt
- $10.6B
- Total Assets
- $48.0B
- Total Liabilities
- $22.9B
- Shareholders' Equity
- $19.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.41B
- Capital Expenditure
- $155M
- Free Cash Flow
- $5.25B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $3.71
- Beta (5Y)
- 1.09
Every ratio is calculated from the company’s reported figures.